Wolverine Trading’s Pacira BioSciences PCRX Stock Holding History

Wolverine Trading’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$289K	Buy	+11,400	New	+$280K	﹤0.01%	4435
2024 Q4	–	Sell	-10,200	Closed	-$148K	–	5712
2024 Q3	$148K	Buy	+10,200	New	+$174K	﹤0.01%	4227
2023 Q2	–	Sell	-19,100	Closed	-$767K	–	4765
2023 Q1	$767K	Buy	+19,100	New	+$760K	﹤0.01%	2131
2019 Q4	–	Sell	-5,700	Closed	-$228K	–	5046
2019 Q3	$228K	Sell	5,700 -5,000	-47%	-$200K	﹤0.01%	3442
2019 Q2	$465K	Sell	10,700 -3,900	-27%	-$166K	﹤0.01%	2788
2019 Q1	$556K	Buy	14,600 +2,100	+17%	+$82K	﹤0.01%	2652
2018 Q4	$531K	Buy	+12,500	New	+$583K	﹤0.01%	2572
2017 Q4	–	Sell	-14,800	Closed	-$556K	–	5338
2017 Q3	$556K	Buy	+14,800	New	+$596K	﹤0.01%	2498
2017 Q2	–	Sell	-23,800	Closed	-$1.09M	–	4790
2017 Q1	$1.09M	Sell	23,800 -2,100	-8%	-$90.8K	0.01%	1652
2016 Q4	$837K	Sell	25,900 -1,000	-4%	-$33.4K	﹤0.01%	2088
2016 Q3	$915K	Buy	26,900 +14,400	+115%	+$564K	﹤0.01%	1948
2016 Q2	$475K	Buy	+12,500	New	+$614K	﹤0.01%	2279

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's PCRX Position: Q4 2022 in Review

Wolverine Trading sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 4,058 shares — an estimated $220K sold.

Wolverine Trading first reported a position in PCRX in Q3 2016 and held it in 3 quarters. The position peaked at $699K in Q3 2016. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

Wolverine Trading reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
Wolverine Trading sold 4,058 Pacira BioSciences shares in Q4 2022, an estimated $220K.
Wolverine Trading first reported a position in Pacira BioSciences in Q3 2016 and held it in 3 quarters.
Wolverine Trading's Pacira BioSciences position peaked at $699K in Q3 2016.
273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.